Mark Erlander
Chief Executive Officer chez CARDIFF ONCOLOGY, INC.
Fortune : 130 729 $ au 31/03/2024
Profil
Mark Erlander is currently the Chief Executive Officer & Director at Cardiff Oncology, Inc. He previously held positions as the Chief Scientific Officer at Biotheranostics, Inc., Assistant Professor at The Scripps Research Institute, Chief Scientific Officer at Gensignia Life Sciences, Inc., and Chief Scientific Officer at Arcturus Studios Holdings, Inc. He also worked as a Principal at Johnson & Johnson.
Dr. Erlander holds a doctorate degree from the University of California, Los Angeles, a graduate degree from Iowa State University, and an undergraduate degree from the University of California, Davis.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CARDIFF ONCOLOGY, INC.
0,05% | 07/03/2024 | 24 481 ( 0,05% ) | 130 729 $ | 31/03/2024 |
Postes actifs de Mark Erlander
| Sociétés | Poste | Début |
|---|---|---|
| CARDIFF ONCOLOGY, INC. | Chief Executive Officer | 08/05/2020 |
Anciens postes connus de Mark Erlander
| Sociétés | Poste | Fin |
|---|---|---|
Gensignia Life Sciences, Inc.
 Gensignia Life Sciences, Inc. BiotechnologyHealth Technology Gensignia Life Sciences, Inc. is a molecular diagnostics company that develops new molecular diagnosis techniques. The private company is based in San Diego, CA. The company was founded by Gabriele Marco Antonio Cerrone. | Chief Tech/Sci/R&D Officer | 01/03/2014 |
Biotheranostics, Inc.
 Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 01/02/2013 |
Arcturus Studios Holdings, Inc.
 Arcturus Studios Holdings, Inc. Packaged SoftwareTechnology Services Arcturus Studios Holdings, Inc. specializes in editing and compressing volumetric video through their holostream and holosuite products. Arcturus Studios Holdings is based in Beverly Hills, CA and has subsidiaries in Canada. These products provide adaptive streaming volumetric video for uninterrupted experiences delivered on demand. The company has received positive feedback from clients such as Crescent Studios, Far East Company, Inc., and NTT Docomo, Inc. for their professional-grade tools and ability to anticipate customer needs. Holoedit and holosuite have been used in various projects, including those featuring BTS and the 2019 Samsung Developer Conference. The company was founded by Devin Horsman, Andy Stack, and Ewan Johnson, and the CEO is Kamal Mistry. | Chief Tech/Sci/R&D Officer | 01/01/2008 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01/01/2000 |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | Corporate Officer/Principal | 01/01/1994 |
Formation de Mark Erlander
| University of California, Los Angeles | Doctorate Degree |
| Iowa State University | Graduate Degree |
| University of California, Davis | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| CARDIFF ONCOLOGY, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Health Services |
Gensignia Life Sciences, Inc.
Gensignia Life Sciences, Inc. BiotechnologyHealth Technology Gensignia Life Sciences, Inc. is a molecular diagnostics company that develops new molecular diagnosis techniques. The private company is based in San Diego, CA. The company was founded by Gabriele Marco Antonio Cerrone. | Health Technology |
Arcturus Studios Holdings, Inc.
Arcturus Studios Holdings, Inc. Packaged SoftwareTechnology Services Arcturus Studios Holdings, Inc. specializes in editing and compressing volumetric video through their holostream and holosuite products. Arcturus Studios Holdings is based in Beverly Hills, CA and has subsidiaries in Canada. These products provide adaptive streaming volumetric video for uninterrupted experiences delivered on demand. The company has received positive feedback from clients such as Crescent Studios, Far East Company, Inc., and NTT Docomo, Inc. for their professional-grade tools and ability to anticipate customer needs. Holoedit and holosuite have been used in various projects, including those featuring BTS and the 2019 Samsung Developer Conference. The company was founded by Devin Horsman, Andy Stack, and Ewan Johnson, and the CEO is Kamal Mistry. | Technology Services |
